COVID-19 Update for Fertility Patients
03/17/20 Update: As you are all well aware, the situation with COVID-19 is continuing to rapidly evolve and we have been continuing to adapt to best follow the recommendations from NYP, the CDC and the American Society for Reproductive Medicine (ASRM). In light of the information from all these sources and new recommendations released this afternoon from ASRM, and in order to best see to the safety of our patients, community, and the healthcare system, we will be suspending initiation of new treatment cycles. When we will be able to resume is not clear and we will continue to closely monitor the situation and adjust as possible. We are continuing to see both new and existing patients via telehealth (video conferencing or phone).
At this time, Columbia University Fertility Center is monitoring the situation with novel coronavirus (COVID-19) closely.
While pregnant women experience immunologic changes that may make them susceptible to respiratory illnesses and may be at higher risk for severe illness, there are not specific data on COVID-19. The Centers for Disease Control and Prevention (CDC) recommends that “pregnant women should engage in usual preventive actions to avoid infection like washing hands and avoiding people who are sick.” The CDC also recommends that travelers avoid all nonessential travel to Level 3 regions (China, Iran, S. Korea, Italy) and that those with chronic medical conditions avoid Level 2 regions (Japan). The CDC has not recommended against attempting to conceive naturally or with assistance.
For your safety and the safety of our staff and other patients, if you have been exposed to COVID-19 or may be at risk, we ask that you inform us and postpone treatment until cleared by your primary care provider.
For more information please visit: